Data / Research funding / Florida / Roskamp Institute, Inc.
Roskamp Institute, Inc.: 13 NIH awards ($5.8M), fiscal years 2021 to 2026
Roskamp Institute, Inc. in Sarasota, FL is funded under 13 NIH awards ($5.8M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- V17JAHQF87A1
- State
- Florida
Awards
13 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Neurological effects of aerosolized red tide neurotoxins | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,405,024 | September 1, 2024 | June 30, 2029 | ABDULLAH, LAILA | reporter.nih.gov |
| Influence of microglial cell depletion and repopulation on aducanumab induced ARIA and vascular lesions in APOE4 carriers with AD | NIH | National Institute on Aging | 2024 to 2025 | $468,875 | September 1, 2024 | May 31, 2027 | OJO, JOSEPH O | reporter.nih.gov |
| Cerebrovascular contributions to APOE4-mediated brain bioenergetic deficits in Alzheimer's disease | NIH | National Institute on Aging | 2023 | $449,460 | September 1, 2023 | August 31, 2025 | ABDULLAH, LAILA | reporter.nih.gov |
| Aberrant PTEN signaling in chronically activated microglia drives tau pathology, neurodegeneration and cognitive decline following repetitive brain injury | NIH | National Institute on Aging | 2024 | $449,460 | June 15, 2024 | May 31, 2026 | OJO, JOSEPH O | reporter.nih.gov |
| The role of PPARγ in astrocyte pathobiology after exposure to repetitive mild traumatic brain injury | NIH | National Institute on Aging | 2023 | $449,444 | September 1, 2023 | August 31, 2025 | OJO, JOSEPH O | reporter.nih.gov |
| The role of adaptive immunity in organophosphate induced CNS injury | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $448,569 | September 1, 2023 | August 31, 2026 | ABDULLAH, LAILA | reporter.nih.gov |
| Targeting the astrocyte-cerebrovasculature system to correct brain bioenergetics defects associated with APOE4 | NIH | National Institute on Aging | 2025 | $341,000 | January 1, 2025 | December 31, 2026 | NKILIZA, AURORE | reporter.nih.gov |
| THE ROLE OF PTEN IN MICROGLIAL PATHOBIOLOGY AFTER EXPOSURE TO REPETITIVE MILD TBI | NIH | National Institute on Aging | 2022 to 2023 | $326,880 | August 15, 2022 | July 31, 2025 | OJO, JOSEPH O | reporter.nih.gov |
| Influence of APOE4 genotype on microglial pathobiology and tau pathology after repetitive mTBI | NIH | National Institute on Aging | 2023 to 2024 | $326,880 | December 1, 2022 | November 30, 2025 | OJO, JOSEPH O | reporter.nih.gov |
| The role of PPARγ in microglia pathobiologyafter exposure to repetitive mild traumatic brain injury | NIH | National Institute on Aging | 2022 to 2023 | $326,878 | February 1, 2022 | January 31, 2025 | OJO, JOSEPH O | reporter.nih.gov |
| The effects of APOE4 on carnitine/acylcarnitine mediated bioenergetic deficits in Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2022 | $324,000 | March 15, 2021 | February 29, 2024 | ABDULLAH, LAILA | reporter.nih.gov |
| Influence of APOE genotype on cerebrovascular cell pathobiology in AD, and the contribution of microglia inflammation | NIH | National Institute on Aging | 2021 to 2022 | $323,982 | August 15, 2021 | June 30, 2024 | OJO, JOSEPH O | reporter.nih.gov |
| Long term assessment of neurological effects after red tide exposure | NIH | National Institute of Environmental Health Sciences | 2021 | $190,100 | May 1, 2020 | April 30, 2023 | ABDULLAH, LAILA | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 3 | $1,297,079 | 0 | $0 |
| 2024 | 5 | $1,735,020 | 0 | $0 |
| 2023 | 6 | $1,633,492 | 0 | $0 |
| 2022 | 4 | $650,870 | 0 | $0 |
| 2021 | 3 | $514,091 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Neurosciences
- Aging
- Brain Disorders
- Neurodegenerative
- Acquired Cognitive Impairment
- Dementia
- Genetics
- Alzheimer's Disease
- Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
- Physical Injury - Accidents and Adverse Effects
- Traumatic Brain Injury (TBI)
- Traumatic Head and Spine Injury
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.